The list includes 49 medications for chronic conditions and 51 for acute care, with an aim of informing efforts to improve supply chain reliability, according to a March 4 news release from the nonprofit organization.
The analysis, based on data from sources including the USP Medicine Supply Map, found that 71% of the drugs identified as the most vulnerable are injectables, including sodium chloride injection, dextrose injection, heparin sodium injection, propofol and lidocaine hydrochloride injection.
The report also highlights that while 61% of the medicines listed were not in shortage as of January 2025, they remain at high risk of shortage.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
